Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 981 of 6351
-
Can a One-Day catheter beat the stent for kidney stone recovery?
Disease control Recruiting nowSeveral studies evaluated the benefit of a short-term external ureteral catheter (UC) compared to double-J (DJ) ureteral stent after flexible ureteroscopy (URS); the results were controversial. These studies had combined analyses of ureteral and renal stones with a high risk of s…
Sponsor: Al-Azhar University • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New combo shot aims to stop early breast cancer from returning
Disease control OngoingThis research study is studying a combination of HER2-directed therapies (trastuzumab and pertuzumab) and hormonal therapy as a treatment after surgery for hormone receptor positive breast cancer. The study drugs involved in this study are: * A combination of trastuzumab and pe…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a double-dose flu vaccine protect vulnerable transplant patients better?
Vaccine OngoingThe influenza virus is a significant cause of morbidity in adult solid organ transplant (SOT) recipients. However, these individuals show a suboptimal response to vaccines including the standard-dose (SD) inactivated influenza vaccine (IIV). Recent studies have investigated two s…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Vaccine
Last updated Jun 27, 2026 08:13 UTC
-
New combo targets tough pancreatic tumors
Disease control Recruiting nowThis phase I/II trial studies the safety, side effects and best dose of M3814 and to see how well it works when given together with radiation therapy in treating patients with pancreatic cancer that has spread to nearby tissue or lymph nodes (locally advanced). M3814 may stop the…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug combo shows promise for Hard-to-Treat HER2 cancers
Disease control OngoingThis trial studies how well tucatinib works for solid tumors that make either more HER2 or a different type of HER2 than usual (HER2 alterations) The solid tumors studied in this trial have either spread to other parts of the body (metastatic) or cannot be removed completely with…
Phase 2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could a tiny neck implant calm rheumatoid arthritis without pills?
Disease control OngoingThe RESET-RA study will assess the safety and efficacy of the SetPoint System (study device) for the treatment of adult patients with active, moderate to severe rheumatoid arthritis who have had an inadequate response or intolerance to biologic or targeted synthetic Disease-Modif…
Phase 3 • Sponsor: SetPoint Medical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can modern Radiotherapy's late effects be predicted?
Knowledge-focused Recruiting nowThe goal of the HARMONIC-RT study is to evaluate late health and social outcomes of contemporary techniques of external beam radiotherapy in paediatric patients, based on the setting-up of a European, long-term registry complemented by a biobank.
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Electric brain zaps and mind tricks: a new combo to fight Post-Surgical pain?
Symptom relief CompletedThe purpose of this study is to determine whether a new medical technology can help reduce post-operative total knee or hip pain when combined with a Cognitive-Behavioral intervention (CBI). This new medical technology, is called transcranial direct current stimulation (tDCS), i…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Can a computer predict which organ donors will save lives?
Knowledge-focused CompletedEvery year, thousands of Canadians receive life-saving, cost-effective organ transplants, while thousands more still wait or die because not enough organs are available. Patients with non-recoverable illnesses, who are undergoing withdrawal of life sustaining measures, can donate…
Sponsor: Ottawa Hospital Research Institute • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Immunotherapy combo shows promise in preventing High-Risk uterine cancer return
Disease control OngoingThe purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, with respect to disease-free survival (DFS) as assessed radiographically by the investigator or by histopathologic confirmation of sus…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a CVP set restore amniotic fluid and improve newborn health?
Disease control CompletedThis prospective, two-arm, non-randomized comparative interventional study evaluated the effectiveness of amnioinfusion using a central venous pressure (CVP) set compared with conventional transabdominal amnioinfusion in pregnant women with preterm premature rupture of membranes …
Sponsor: Herlambang Herlambang • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can a switch to goat milk formula prevent baby eczema?
Prevention OngoingTo determine the relative risk of developing atopic dermatitis in infants fed a study formula based on whole goat milk compared to infants a study formula based on cow milk protein.
Sponsor: Dairy Goat Co-operative (N.Z.) Limited • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
New hope for stubborn lung infection: bedaquiline combo shows promise
Disease control CompletedThe purpose of the study is to evaluate the efficacy of bedaquiline (BDQ) compared with rifamycin when administered as part of a treatment regimen with clarithromycin (CAM) and ethambutol (EB) in adult participants with treatment-refractory Mycobacterium avium complex-lung diseas…
Phase 2/3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could adding radiation to immunotherapy keep lung cancer at bay?
Disease control PausedThis phase II/III trial compares the effect of adding radiation therapy to the usual maintenance therapy with atezolizumab versus atezolizumab alone in patients who have already received atezolizumab plus chemotherapy for the treatment of small cell lung cancer that has spread ou…
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Mobile CT vans aim to detect lung cancer in smokers as young as 40
Diagnosis Recruiting nowLow-dose CT Screening has been shown in two large trials in the United States (NLST) and Europe (NELSON) to increase overall survival in subjects 55 years of age and older with a strong smoking history. Unfortunately, in both North Carolina (NC) and South Carolina (SC), subjects …
Sponsor: Wake Forest University Health Sciences • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
New hope for rare leukemia: drug targets MEK gene in BRAF-Negative patients
Disease control Recruiting nowBackground: Most people with hairy cell leukemia have a BRAF gene mutation. They can be treated with BRAF inhibitors, drugs that target this mutation. For people who do not have this mutation, BRAF inhibitors are not a treatment option. We found that in hairy cell leukemia, when…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Promising new combo tackles tough bone cancer
Disease control CompletedThis study evaluates the trabectedin and irinotecan in the treatment of Ewings sarcoma, with a EWS-FLI1 mutation. Patients will also receive an infusion of 18F-FLT in combination with a Positron Emission Tomography (PET) scan to help evaluate the effect of treatment.
Phase 1/2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can zapping a few spots keep lung cancer in check?
Disease control OngoingA registry-based randomized screening phase II trial. A total of 68 patients with metastatic non small cell lung cancer on systemic therapy with oligoprogression to 1-5 extracranial lesions will be randomized using a 1:1 ratio to standard of care (begin next-line systemic therapy…
Phase 2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat sarcomas
Disease control OngoingThe hypothesis of this study is that the response rate of soft tissue sarcoma will be improved with the addition of PD-1 and CTLA-4 inhibition to cabozantinib, and that cabozantinib priming will increase the response to nivolumab and ipilimumab.
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
ER-based program aims to stop opioid addiction before it starts in young people
Prevention CompletedThe purpose of the study is to develop and test innovative interventions to prevent the development of opioid misuse and opioid use disorders among older adolescents and young adults (AYA; ages 16-30) who use opioids, which will be initiated from a health care visit in the emerge…
Sponsor: University of Michigan • Aim: Prevention
Last updated Aug 27, 2026 00:00 UTC